Healthequity Inc [HQY] stock is trading at $82.79, up 1.41%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HQY shares have gain 4.29% over the last week, with a monthly amount glided 2.14%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 19, March 2024, HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results. In a post published today on Yahoo Finance, Highlights of the fiscal year include:.
From an analyst’s perspective:
Healthequity Inc [NASDAQ: HQY] stock has seen the most recent analyst activity on April 02, 2024, when JP Morgan reiterated its Overweight rating and also boosted its price target to $108 from $86. Previously, Barclays started tracking the stock with Overweight rating on January 03, 2024, and set its price target to $84. On September 21, 2023, upgrade upgraded it’s rating to Outperform and revised its price target to $87 on the stock. Goldman upgraded its rating to a Neutral and increased its price target to $77 on October 21, 2022. KeyBanc Capital Markets initiated its recommendation with a Overweight and recommended $85 as its price target on September 16, 2022. Goldman started tracking with a Sell rating for this stock on July 12, 2022, and assigned it a price target of $59. In a note dated April 11, 2022, Wells Fargo initiated an Overweight rating and provided a target price of $95 on this stock.
Healthequity Inc [HQY] stock has fluctuated between $48.86 and $84.49 over the past year. Currently, Wall Street analysts expect the stock to reach $92.8 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $82.79 at the most recent close of the market. An investor can expect a potential return of 12.09% based on the average HQY price forecast.
Analyzing the HQY fundamentals
Healthequity Inc [NASDAQ:HQY] reported sales of 999.59M for the trailing twelve months, which represents a growth of 12.21%. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.12%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 81.40 points at the first support level, and at 80.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 83.74, and for the 2nd resistance point, it is at 84.70.
Healthequity Inc [HQY] reported earnings per share of $0.63 for its fiscal quarter that ended on 1/30/2024. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.56/share, meaning a difference of $0.07 and a surprise factor of 12.50%. By comparison, the stated earnings for the previous quarter ended on 10/30/2023 were $0.6 per share as compared to estimates of $0.5 per share, a difference of $0.1 representing a surprise of 20.00%.
Ratios To Look Out For
For context, Healthequity Inc’s Current Ratio is 4.76. In addition, the Quick Ratio stands at 4.76 and the Cash Ratio stands at 3.45. Considering the valuation of this stock, the price to sales ratio is 7.14, the price to book ratio is 3.50 and price to earnings (TTM) ratio is 129.35.
Transactions by insiders
Recent insider trading involved Dilsaver Evelyn S, Director, that happened on Mar 26 ’24 when 32500.0 shares were sold. PRESIDENT AND CEO, Kessler Jon completed a deal on Mar 22 ’24 to sell 33765.0 shares. Meanwhile, EVP, GC & CORPORATE SECRETARY Ladd Delano sold 2558.0 shares on Mar 01 ’24.
